Raymond James & Associates’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $498K | Buy |
|
|||||
|
2024
Q2 | $332K | Sell |
|
|||||
|
2024
Q1 | $728K | Sell |
|
|||||
|
2023
Q4 | $771K | Sell |
|
|||||
|
2023
Q3 | $776K | Sell |
|
|||||
|
2023
Q2 | $1.35M | Buy |
|
|||||
|
2023
Q1 | $1.44M | Sell |
|
|||||
|
2022
Q4 | $1.33M | Sell |
|
|||||
|
2022
Q3 | $3.87M | Buy |
|
|||||
|
2022
Q2 | $2.02M | Sell |
|
|||||
|
2022
Q1 | $2.15M | Sell |
|
|||||
|
2021
Q4 | $2.41M | Buy |
|
|||||
|
2021
Q3 | $2.37M | Sell |
|
|||||
|
2021
Q2 | $1.66M | Buy |
|
|||||
|
2021
Q1 | $1.12M | Buy |
|
|||||
|
2020
Q4 | $845K | Buy |
|
|||||
|
2020
Q3 | $532K | Sell |
|
|||||
|
2020
Q2 | $312K | Buy |
|
|||||
|
2020
Q1 | $238K | Buy |
|
|||||
|
2019
Q4 | $374K | Sell |
|
|||||
|
2019
Q3 | $346K | Buy |
|
|||||
|
2019
Q2 | $195K | Sell |
|
|||||
|
2019
Q1 | $390K | Buy |
|
|||||
|
2018
Q4 | $555K | Buy |
|
|||||
|
2018
Q3 | $451K | Sell |
|
|||||
|
2018
Q2 | $346K | Buy |
|
|||||
|
2018
Q1 | $230K | Buy |
|
|||||
|
2017
Q4 | $180K | Buy |
|
|||||
|
2017
Q3 | $260K | Sell |
|
|||||
|
2017
Q2 | $370K | Buy |
|